Lisata Therapeutics, Inc. (LSTA)
3.47
-0.01
(-0.29%)
USD |
NASDAQ |
Jun 09, 14:39
Lisata Therapeutics SG&A Expense (Quarterly) : 3.738M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| KalVista Pharmaceuticals, Inc. | 48.80M |
| ACADIA Pharmaceuticals, Inc. | 171.02M |
| Alnylam Pharmaceuticals, Inc. | 322.55M |
| Savara, Inc. | 15.57M |
| Vericel Corp. | 49.23M |